Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil

2011 ◽  
Vol 55 (4) ◽  
pp. 858-865 ◽  
Author(s):  
Chao-Yu Hsu ◽  
Ying-Chun Shen ◽  
Chih-Wei Yu ◽  
Chiun Hsu ◽  
Fu-Chang Hu ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document